Fabrício A Pamplona Selected Research

Fabrício A Pamplona Research Topics

5	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2010 - 12/2005
1	Alzheimer Disease (Alzheimer's Disease) 01/2017
1	Memory Disorders (Memory Loss) 01/2017
1	Cognitive Dysfunction 01/2017
1	Substance-Related Disorders (Drug Abuse) 09/2014
1	Brain Diseases (Brain Disorder) 08/2014
1	Body Weight (Weight, Body) 12/2010
1	Pain (Aches) 09/2010
1	Catalepsy 02/2010
1	Anxiety Disorders (Anxiety Disorder) 11/2006

3	Pharmaceutical PreparationsIBA 09/2014 - 03/2009
2	Peptides (Polypeptides)IBA 01/2017 - 09/2010
2	Caffeine (No Doz)FDA LinkGeneric 12/2010 - 12/2005
2	Cannabinoid Receptor AgonistsIBA 06/2007 - 11/2006
1	icatibantIBA 01/2017
1	BradykininIBA 01/2017
1	Bradykinin Receptors (Bradykinin Receptor)IBA 01/2017
1	Bradykinin B1 ReceptorIBA 01/2017
1	Ethanol (Ethyl Alcohol)IBA 09/2014
1	PrionsIBA 08/2014
1	Dopamine (Intropin)FDA LinkGeneric 08/2014
1	Desipramine (Pertofrane)FDA LinkGeneric 09/2010
1	Amyloid beta-PeptidesIBA 09/2010
1	LipoxinsIBA 02/2010
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010
1	Methylphenidate (Ritalin)FDA LinkGeneric 03/2009
1	Purinergic P1 Receptor AntagonistsIBA 03/2009
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 03/2009
1	CannabinoidsIBA 06/2007
1	(3R)- ((2,3- dihydro- 5- methyl- 3- ((4- morpholinyl)methyl)pyrrolo- (1,2,3- de)- 1,4- benzoxazin- 6- yl)(1- naphthalenyl))methanone (WIN 55,212)IBA 06/2007
1	Cocaine (Cocaine HCl)IBA 02/2007
1	Analgesics (Analgesic Drugs)IBA 02/2007

1	Therapeutics 12/2010